Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Delek US
DK
$3.87B
| $74.8M | 0.2% |
+2,599,200
| New | +$91.2M |
|
102
M&T Bank
MTB
$36.2B
| $74.6M | 0.2% |
+667,550
| New | +$68.8M |
|
|
SIX
103
DELISTED
Six Flags Entertainment Corp.
SIX
| $73.7M | 0.19% |
+2,095,500
| New | +$78.2M |
|
104
Franklin Resources
BEN
$16.9B
| $73.6M | 0.19% |
+1,623,600
| New | +$82.7M |
|
105
Starbucks
SBUX
$118B
| $73.2M | 0.19% |
+2,236,200
| New | +$69.5M |
|
106
Broadcom
AVGO
$1.82T
| $71.6M | 0.19% |
+19,166,000
| New | +$66.8M |
|
107
Flowers Foods
FLO
$1.64B
| $70.9M | 0.19% |
+3,216,063
| New | +$70.5M |
|
|
DFS
108
DELISTED
Discover Financial Services
DFS
| $70M | 0.18% |
+1,470,300
| New | +$67.5M |
|
109
Intercontinental Exchange
ICE
$82.4B
| $69.5M | 0.18% |
+1,954,000
| New | +$65.5M |
|
110
Dillards
DDS
$8.87B
| $68.9M | 0.18% |
+840,700
| New | +$71.1M |
|
|
CTXS
111
DELISTED
Citrix Systems Inc
CTXS
| $68.9M | 0.18% |
+1,432,604
| New | +$73.9M |
|
112
Travelers Companies
TRV
$80.8B
| $68.6M | 0.18% |
+858,872
| New | +$72.2M |
|
113
Healthpeak Properties
DOC
$15.4B
| $68M | 0.18% |
+1,644,145
| New | +$75M |
|
114
GSK
GSK
$103B
| $67.8M | 0.18% |
+1,086,000
| New | +$68.9M |
|
115
Oil States International
OIS
$522M
| $66.8M | 0.18% |
+1,262,100
| New | +$64.4M |
|
|
SHPG
116
DELISTED
Shire pic
SHPG
| $65.6M | 0.17% |
+690,112
| New | +$64.7M |
|
|
VGR
117
DELISTED
Vector Group Ltd.
VGR
| $64.9M | 0.17% |
+7,941,804
| New | +$64.3M |
|
118
Commault Systems
CVLT
$5.89B
| $64.7M | 0.17% |
+851,900
| New | +$62.7M |
|
|
GAP
119
The Gap Inc
GAP
$6.84B
| $64.4M | 0.17% |
+1,543,600
| New | +$60.8M |
|
120
Whirlpool
WHR
$2.42B
| $64M | 0.17% |
+559,357
| New | +$67.8M |
|
|
APC
121
DELISTED
Anadarko Petroleum
APC
| $63.9M | 0.17% |
+743,800
| New | +$64M |
|
|
PCP
122
DELISTED
PRECISION CASTPARTS CORP
PCP
| $63.6M | 0.17% |
+281,400
| New | +$57M |
|
123
Teradata
TDC
$2.68B
| $63.2M | 0.17% |
+1,258,800
| New | +$67.8M |
|
124
Cognizant
CTSH
$21.5B
| $62.8M | 0.16% |
+2,006,352
| New | +$66.7M |
|
125
Johnson & Johnson
JNJ
$635B
| $62.5M | 0.16% |
+727,400
| New | +$61.7M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.